. . . . . . . . . . . "a(CHEBI:metformin) -| bp(MESHPP:\"Insulin Resistance\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "The greater suppression of hepatic glucose production with glyburide (76) has been offered as an explanation for the higher incidence of hypoglycemia Metformin enhances the sensitivity of both hepatic and peripheral tissues (primarily muscle) to insulin (92-94) (Table 1, Figure 1). Metformin inhibits hepatic gluconeogenesis both in vitro (95) and in vivo" . . "Selventa" . . . . "2014-07-03T14:31:31.657+02:00"^^ . . .